Fisher & Paykel Healthcare Corporation Limited
FPH.NZ

$13.24 B
Marketcap
$22.58
Share price
Country
$-0.34
Change (1 day)
$23.03
Year High
$13.24
Year Low

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

marketcap

P/S ratio for Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

P/S ratio as of 2024: 8.66

According to Fisher & Paykel Healthcare Corporation Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.66. At the end of 2023 the company had a P/S ratio of 9.70.

P/S ratio history for Fisher & Paykel Healthcare Corporation Limited from 2001 to 2024

P/S ratio at the end of each year

Year P/S ratio
2024 8.66
2023 9.70
2022 8.55
2021 9.46
2020 13.70
2019 8.00
2018 7.93
2017 5.80
2016 6.05
2015 5.61
2014 3.80
2013 2.22
2012 1.99
2011 2.56
2010 2.72
2009 2.71
2008 3.71
2007 4.69
2006 6.23
2005 5.80
2004 4.94
2003 4.18
2002 4.33
2001 1.87